Gerbatin RR[au] - Search Results

Year	Number of Results
2013	1
2018	1
2019	3
2020	1
2022	2
2023	0

1

Investigation of MicroRNA-134 as a Target against Seizures and SUDEP in a Mouse Model of Dravet Syndrome.

Gerbatin RR, Augusto J, Morris G, Campbell A, Worm J, Langa E, Reschke CR, Henshall DC. Gerbatin RR, et al. eNeuro. 2022 Sep 27;9(5):ENEURO.0112-22.2022. doi: 10.1523/ENEURO.0112-22.2022. Print 2022 Sep-Oct. eNeuro. 2022. PMID: 36240080 Free PMC article.

2

Guanosine Attenuates Behavioral Deficits After Traumatic Brain Injury by Modulation of Adenosinergic Receptors.

Dobrachinski F, Gerbatin RR, Sartori G, Golombieski RM, Antoniazzi A, Nogueira CW, Royes LF, Fighera MR, Porciúncula LO, Cunha RA, Soares FAA. Dobrachinski F, et al. Among authors: gerbatin rr. Mol Neurobiol. 2019 May;56(5):3145-3158. doi: 10.1007/s12035-018-1296-1. Epub 2018 Aug 13. Mol Neurobiol. 2019. PMID: 30105669

3

Life-span characterization of epilepsy and comorbidities in Dravet syndrome mice carrying a targeted deletion of exon 1 of the Scn1a gene.

Gerbatin RR, Augusto J, Boutouil H, Reschke CR, Henshall DC. Gerbatin RR, et al. Exp Neurol. 2022 Aug;354:114090. doi: 10.1016/j.expneurol.2022.114090. Epub 2022 Apr 26. Exp Neurol. 2022. PMID: 35487274 Free article.

4

Genetic deletion of microRNA-22 blunts the inflammatory transcriptional response to status epilepticus and exacerbates epilepsy in mice.

Almeida Silva LF, Reschke CR, Nguyen NT, Langa E, Sanz-Rodriguez A, Gerbatin RR, Temp FR, de Freitas ML, Conroy RM, Brennan GP, Engel T, Henshall DC. Almeida Silva LF, et al. Among authors: gerbatin rr. Mol Brain. 2020 Aug 21;13(1):114. doi: 10.1186/s13041-020-00653-x. Mol Brain. 2020. PMID: 32825833 Free PMC article.

5

Delayed creatine supplementation counteracts reduction of GABAergic function and protects against seizures susceptibility after traumatic brain injury in rats.

Gerbatin RR, Silva LFA, Hoffmann MS, Della-Pace ID, do Nascimento PS, Kegler A, de Zorzi VN, Cunha JM, Botelho P, Neto JBT, Furian AF, Oliveira MS, Fighera MR, Royes LFF. Gerbatin RR, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:328-338. doi: 10.1016/j.pnpbp.2019.02.004. Epub 2019 Feb 8. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30742861

6

A₁ rather than A_2A adenosine receptor as a possible target of Guanosine effects on mitochondrial dysfunction following Traumatic Brain Injury in rats.

Gerbatin RR, Dobrachinski F, Cassol G, Soares FAA, Royes LFF. Gerbatin RR, et al. Neurosci Lett. 2019 Jun 21;704:141-144. doi: 10.1016/j.neulet.2019.04.014. Epub 2019 Apr 8. Neurosci Lett. 2019. PMID: 30974229

7

Antioxidant activity elicited by low dose of caffeine attenuates pentylenetetrazol-induced seizures and oxidative damage in rats.

Souza MA, Mota BC, Gerbatin RR, Rodrigues FS, Castro M, Fighera MR, Royes LF. Souza MA, et al. Among authors: gerbatin rr. Neurochem Int. 2013 May;62(6):821-30. doi: 10.1016/j.neuint.2013.02.021. Epub 2013 Feb 26. Neurochem Int. 2013. PMID: 23485558 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

7 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year